Here are five key points:
1. Patent No. 9,649,203, Methods of Post-Filling an Intervertebral Implant, outlines the delivery of graft material to a spinal fusion device’s internal chambers.
2. Pinnacle Spine brought the concept of delivering bone graft material in situ in an implanted device to the market.
3. The company wanted to fill the biologic void other spinal fusion systems leave by introducing a delivery method that accomplishes maximum graft contact with the adjacent vertebral endplates.
4. The company already possessed three other patents regarding its InFill fusion technology.
5. Pinnacle Spine also holds patents in Australia, Canada and Europe.
More articles on devices:
Tyber Medical receives FDA clearance: 5 insights
Vertiflex names new vice president, COO: 5 key notes
CTL Medical Corporation partners with G-21: 3 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
